U.S. jury sides with Amphastar over Momenta in drug patent trial

BOSTON (Reuters) - A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.

Source: Reuters: Health - July 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news